Management changes at Lilly
This article was originally published in Scrip
Alex Azar is to lead Lilly's US business-to-business organisation, effective April 1st. Mr Azar, currently senior vice-president of corporate affairs and communications, becomes vice-president of business-to-business and Puerto Rico – he will oversee the company's public payer, managed care and wholesaler operations in the US and the sales and marketing operations in Puerto Rico. Mr Azar joined Lilly in 2007, having served as deputy secretary of Health and Human Services (HHS) from 2005-07. Lilly has also announced that Jack Bailey, US senior vice-president of account-based markets, will broaden his responsibilities to include oversight of the US diabetes business unit. This adds to his current responsibilities for Lilly USA's oncology and cardiovascular teams, as well as the Lilly Hospital Group.
You may also be interested in...
Like other hand sanitizer manufacturers, WillSpeed Technology claims its GermBloc “kills 99.99% of germs.” Plaintiffs in a proposed class action filed in Massachusetts federal court allege the claim “grossly overstates” the product’s efficacy, deceiving consumers and endangering them with false confidence.
Keeping Track: US FDA Set For Speed With Approvals Of Inqovy, Rukobia, Dojolvy, Phesgo; Keytruda Loses Chance At AA In HCC
The latest drug development news and highlights from the Pink Sheet’s FDA Performance Tracker.
Syndax CEO also says US FDA’s virtual meetings would benefit from having advisory committee members on camera, which may be a technology challenge.